2019 American Transplant Congress
Extremes of Body Mass Index is Associated with Inferior Renal Allograft Outcomes in Type 2 Diabetic Deceased Donor Renal Transplant Recipients
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: We evaluated the trends and renal allograft outcomes in type 2 diabetic renal transplant recipients stratified by body mass index (BMI).*Methods: All adult type…2019 American Transplant Congress
A Novel Program of Directed Domino and Split Liver Donations Increases Liver Transplants
Medstar Georgetown Transplant Institute, Georgetown University Hospital, Washington, DC
*Purpose: Liver transplants have not been performed in directed donor chains as have evolved for kidney transplants. We report an initial experience using domino and…2019 American Transplant Congress
The Efficacy of Spheroidal Hepatocytes for Hepatocyte Transplantation
Department of Gastroenterological Surgery Ⅰ Hokkaido University Graduate School, Sapporo, Japan
*Purpose: Hepatocyte transplantation (HCTx) is expected to expand its application as a next generation therapy alternative to liver transplantation. Following HCTx, the liver function improves…2019 American Transplant Congress
Orthotopic Liver Transplantation in MPV17 Deficiency: A Case Series
*Purpose: The purpose of this study was to consider the clinical courses of two patients with MPV17 mutations and to evaluate the efficacy of liver…2019 American Transplant Congress
Metabolomic Study Of Sarcopenia In Patients Prior To Liver Transplantation
1Surgery, Indiana University, Indianapolis, IN, 2University of Washington, Seattle, WA
*Purpose: Sarcopenia is defined as the loss of muscle mass, typically associated with aging, but frequently appearing in liver disease patients. In particular, sarcopenia present…2019 American Transplant Congress
Contribution of CD38 to Methionine Choline Deficient (MCD) Diet-Induced Liver Injury in Rats
Department of Cardiac Surgery, The Ohio State Univ. Medical Center, Columbus, OH
*Purpose: Nonalcoholic fatty liver disease (NAFLD) and associated non-alcoholic steatohepatitis (NASH) is a rising cause of end stage liver disease, increasing the need for liver…2019 American Transplant Congress
Treatment of Cardiovascular Risk Factors Improves Long Term Outcome Post Liver Transplantation
Washington University in St Louis, Saint Louis, MO
*Purpose: Cardiovascular (CV) disease is a leading cause of mortality 1 year after liver transplantation (LT). We aimed to assess the effect of treating CV…2019 American Transplant Congress
BMI Influence on the Outcomes of Renal Transplant
*Purpose: Our aim was to assess the effect of body mass index (BMI) on the outcomes of renal transplant and the management of obese patients…2019 American Transplant Congress
The Comparison of Glycemic Profiles during Post-Operative Early Period between Liver and Kidney Transplantation Assessed by Continuous Glucose Monitoring System
*Purpose: Newly developed hyperglycemia and worsening of previously well controlled glucose control are common after transplantation because of stressful condition and immunosuppressive agents including of…2019 American Transplant Congress
Metabolic Liver Transplantation – Can We Afford It?
*Purpose: Despite major improvement in medical and nutritional care of pediatric patients suffering from intoxication inherited metabolic disorders, their long term outcomes remain guarded. Liver…
American Transplant Congress abstracts